ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LNSR vs MBOT // PIOTROSKI F-SCORE QUALITY

LENSAR Inc. (NASDAQ) VS. Microbot Medical Inc. (NASDAQ) • 15-METRIC TALLY: LNSR 1 — MBOT 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: LNSR
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNSR VS. MBOT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LNSR MBOT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -15.80% -19.20 MBOT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -20.33% -17.42% -2.91 MBOT /fcf-yield <GO>
Operating Margin -47.60% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 12.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 4/9 2/9 +2.00 LNSR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.6 48.5 -13.97 MBOT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $73.3M $75.2M -$1.9M MBOT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LNSR REV MBOT REV LNSR GROSS % MBOT GROSS % LNSR FCF MBOT FCF
FY 2025 $51.7M $0 39.4% — -$14.9M -$13.1M
FY 2024 $46.0M $0 39.9% — -$2.4M -$8.9M
FY 2023 $35.7M $0 — — -$9.7M -$8.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNSR // BETA —
MBOT // BETA —